Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07843641 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Legacy Study in Participants With Gastrointestinal Stromal Tumors (GIST)

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
GlaxoSmithKline
246 trials monitored
See 20 trials at risk
This study aims to evaluate the long-term safety and tolerability of velzatinib (GSK6042981) in adults with GIST who have previously received velzatinib in parent study and continue to benefit from the treatment. Participants will be monitored for side effects and overall health to better understand the effects of long-term treatment and support future care for adults with GIST.
Trial Details
NCT Number NCT07843641
Lead Sponsor GlaxoSmithKline
Conditions
(from sponsor)		 Gastrointestinal Neoplasms
Related terms Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors
Enrollment 72 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov